Ankylosing spondylitis: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: {{subpages}} In medicine and rheumatology, '''ankylosing spondylitis''' is an "inflammatory joint disease affecting the spine. It occurs predominantly in young males and produces p...) |
(No difference)
|
Revision as of 15:31, 1 September 2008
In medicine and rheumatology, ankylosing spondylitis is an "inflammatory joint disease affecting the spine. It occurs predominantly in young males and produces pain and stiffness as a result of inflammation of the sacroiliac, intervertebral, and costovertebral joints. Etiology is unknown."[1][2]
Treatment
TNFR-Fc fusion protein (etanercept - pronounced et a ner' set) blocks the activity of tumor necrosis factor-alpha.[3] and may help patients with ankylosing spondylitis.[4][5]
References
- ↑ Anonymous (2024), Ankylosing spondylitis (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Braun J, Sieper J (April 2007). "Ankylosing spondylitis". Lancet 369 (9570): 1379–90. DOI:10.1016/S0140-6736(07)60635-7. PMID 17448825. Research Blogging.
- ↑ Template:MedMaster
- ↑ Gorman JD, Sack KE, Davis JC (May 2002). "Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha". N. Engl. J. Med. 346 (18): 1349–56. DOI:10.1056/NEJMoa012664. PMID 11986408. Research Blogging.
- ↑ Furst DE, Breedveld FC, Kalden JR, et al (November 2007). "Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007". Ann. Rheum. Dis. 66 Suppl 3: iii2–22. DOI:10.1136/ard.2007.081430. PMID 17934088. Research Blogging.